Pathophysiology of cancer therapy-provoked atrial fibrillation

Wan Li Cheng, Yu Hsun Kao, Shih Ann Chen, Yi Jen Chen

研究成果: 雜誌貢獻回顧型文獻同行評審

20 引文 斯高帕斯(Scopus)


Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.

頁(從 - 到)186-194
期刊International Journal of Cardiology
出版狀態已發佈 - 9月 15 2016

ASJC Scopus subject areas

  • 心臟病學與心血管醫學


深入研究「Pathophysiology of cancer therapy-provoked atrial fibrillation」主題。共同形成了獨特的指紋。